HR 6062
To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill updates the Federal Food, Drug, and Cosmetic Act to ensure the FDA can address shortages of both drugs and life-saving medical devices. It requires manufacturers to notify the FDA of potential shortages and allows for expedited reviews of devices that could alleviate shortages. The bill also expands the FDA’s authority to import devices during shortages to ensure access to critical medical supplies, and creates a comprehensive list of drug and device shortages.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Bill, Jr. Pascrell
Jody B. Hice
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.